First Report of an ST410 OXA-181 and CTX-M-15 Coproducing Escherichia coli Clone in Italy: A Whole-Genome Sequence Characterization

Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease
Aurora PiazzaSara Giordana Rimoldi

Abstract

We investigated an Italian OXA-181-producing Escherichia coli clinical isolate (ECS1_14) by whole-genome sequencing. The strain coharbored blaCTX-M-15, blaCMY-2, and qnrS1 genes; it belonged to ST410(Achtman)/ST692(Pasteur) and phylogroup A. The blaOXA-181 gene was harbored on a plasmid highly similar (99% identity) to the pOXA181_EC14828 plasmid, recently reported in China.

References

Feb 18, 2016·Antimicrobial Agents and Chemotherapy·Abdoul-Salam OuédraogoSylvain Godreuil
May 23, 2016·International Journal of Antimicrobial Agents·Linda FalgenhauerTrinad Chakraborty
Aug 10, 2016·Antimicrobial Agents and Chemotherapy·Nicolas KiefferLaurent Poirel
Nov 22, 2016·The Lancet Infectious Diseases·Hajo GrundmannUNKNOWN European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) Working Group
Feb 16, 2017·The Journal of Antimicrobial Chemotherapy·Jacqueline FindlayNeil Woodford

❮ Previous
Next ❯

Citations

Aug 14, 2019·Antimicrobial Agents and Chemotherapy·Oumar Ouchar MahamatSylvain Godreuil
Nov 15, 2019·Clinical Microbiology Reviews·Johann D D PitoutYasufumi Matsumura
Aug 31, 2019·Future Microbiology·Serena SimoniMarina Mingoia
Oct 3, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Aurélien NiggVincent Perreten

❮ Previous
Next ❯

Software Mentioned

Etest
SPAdes
Vitek2 System

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.